PHASE 2 STUDY OF TELATINIB IN COMBINATION WITH CAPECITABINE AND CISPLATIN AS FIRST-LINE TREATMENT IN PATIENTS WITH ADVANCED CANCER OF THE STOMACH OR GASTRO-ESOPHAGEAL JUNCTION (GEJ)

被引：0
|
作者：
Alsina, M. [1 ]
Ajani, J. A. [2 ]
Ko, A. H. [3 ]
Garcia De Paredes, M. L. [4 ]
Rivera, F. [5 ]
Schwartzberg, L. [6 ]
Phan, A. T. [2 ]
Whiteside, M. [7 ]
Kunkel, L. A. [6 ,8 ]
Tabernero, J. [9 ]
机构：
[1] Vall dHebron Univ Hosp, Dept Oncol, Barcelona, Spain
[2] Univ Texas MD Anderson Canc Ctr, Gastrointestinal Med Oncol Dept, Houston, TX 77030 USA
[3] UCSF Helen Diller Family Comprehens Canc Ctr, Dept Hematol Oncol, San Francisco, CA USA
[4] Hosp Univ Ramon y Cajal, Madrid, Spain
[5] Hosp Univ Marques de Valdecilla, Dept Med Oncol, Santander, Spain
[6] West Clin, Memphis, TN USA
[7] ACT Biotech Inc, Clin Operat, San Francisco, CA USA
[8] ACT Biotech Inc, Clin Dev, San Francisco, CA USA
[9] Vall dHebron Univ Hosp, Med Oncol Serv, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [21] Pembrolizumab in combination with trastuzumab for treatment of HER2-positive advanced gastric or gastro-esophageal junction cancer
    Qureshi, Zaheer
    Jamil, Abdur
    Fatima, Eeshal
    Altaf, Faryal
    Siddique, Rimsha
    Shah, Shivendra
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (08): : 4647 - 4656
  • [22] Phase 2 study of vorinostat combined with capecitabine plus cisplatin as first-line chemotherapy in patients with advanced gastric cancer (AGC)
    Yoo, C.
    Ryu, M. H.
    Na, Y. S.
    Park, S. R.
    Lee, C. W.
    Ryoo, B. Y.
    Kang, Y. K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S430 - S430
  • [23] Phase I dose-finding study of S-1 in combination with docetaxel and oxaliplatin (DOS) as first-line therapy in patients with advanced gastro-esophageal cancer.
    Vestermark, Lene Weber
    Jensen, Helle Anita
    Schoennemann, Katrine Rahbek
    Krogh, Merete
    Pfeiffer, Per
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [24] Current results of a phase I study of DKN-01 in combination with paclitaxel (P) in patients (pts) with advanced DKK1+esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ)
    Ryan, D. P.
    Murphy, J.
    Mahalingam, D.
    Strickler, J.
    Stein, S.
    Sirard, C.
    Landau, S.
    Bendell, J.
    ANNALS OF ONCOLOGY, 2016, 27 : 108 - 108
  • [25] A phase-Ib study of TRK-950 combined with anticancer treatment regimens in patients with gastric and gastro-esophageal junction (GEJ) cancer.
    Cassier, Philippe Alexandre
    Matrana, Marc Ryan
    Hanna, Diana L.
    George, Ben
    Sharma, Sunil
    Kelly, Ronan Joseph
    Okano, Fumiyoshi
    Von Hoff, Daniel D.
    Blay, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 361 - 361
  • [26] Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer
    Rao, S
    Cunningham, D
    Price, T
    Hill, ME
    Ross, PJ
    Tebbutt, N
    Norman, AR
    Oates, J
    Shellito, P
    BRITISH JOURNAL OF CANCER, 2004, 91 (05) : 839 - 843
  • [27] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    Kang, H. J.
    Chang, H. M.
    Kim, T. W.
    Ryu, M-H
    Sohn, H-J
    Yook, J. H.
    Oh, S. T.
    Kim, B. S.
    Lee, J-S
    Kang, Y-K
    BRITISH JOURNAL OF CANCER, 2008, 98 (02) : 316 - 322
  • [28] A phase II study of paclitaxel and capecitabine as a first-line combination chemotherapy for advanced gastric cancer
    H J Kang
    H M Chang
    T W Kim
    M-H Ryu
    H-J Sohn
    J H Yook
    S T Oh
    B S Kim
    J-S Lee
    Y-K Kang
    British Journal of Cancer, 2008, 98 : 316 - 322
  • [29] Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancer
    S Rao
    D Cunningham
    T Price
    M E Hill
    P J Ross
    N Tebbutt
    A R Norman
    J Oates
    P Shellito
    British Journal of Cancer, 2004, 91 : 839 - 843
  • [30] First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
    E van Meerten
    F A L M Eskens
    E C van Gameren
    L Doorn
    A van der Gaast
    British Journal of Cancer, 2007, 96 : 1348 - 1352
12345